Stephen White - Love Hemp Chief Officer
Insider
Stephen White is Chief Officer of Love Hemp Group
| Phone | 44 2039 785 322 |
| Web | https://www.worldhighlife.uk |
Stephen White Latest Insider Activity
Tracking and analyzing the buying and selling activities of Stephen White against Love Hemp pink sheet is an integral part of due diligence when investing in Love Hemp. Stephen White insider activity provides valuable insight into whether Love Hemp is net buyers or sellers over its current business cycle. Note, Love Hemp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Love Hemp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Stephen White over six months ago Disposition of 1636 shares by Stephen White of Stericycle at 52.2 subject to Rule 16b-3 | ||
Stephen White over six months ago Disposition of 3315 shares by Stephen White of Stericycle subject to Rule 16b-3 | ||
Stephen White over six months ago Acquisition by Stephen White of 1872 shares of Stericycle subject to Rule 16b-3 | ||
Stephen White over a year ago Exercise or conversion by Stephen White of 2409 shares of Stericycle subject to Rule 16b-3 |
Love Hemp Management Efficiency
The company has return on total asset (ROA) of (0.6601) % which means that it has lost $0.6601 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.3021) %, meaning that it generated substantial loss on money invested by shareholders. Love Hemp's management efficiency ratios could be used to measure how well Love Hemp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Advocate Ohayon | INC Research Holdings | 35 | |
| Elizabeth JD | ANI Pharmaceuticals | N/A | |
| Raymond Coffman | cbdMD Inc | 62 | |
| Sibyl Swift | cbdMD Inc | 43 | |
| John Weston | cbdMD Inc | N/A | |
| Matthew Coapman | cbdMD Inc | 48 | |
| CCFP DipSportMed | Evolus Inc | 60 | |
| Thomas Flow | Akanda Corp | 46 | |
| Kevin MacDermott | cbdMD Inc | 62 | |
| Muthusamy RPh | ANI Pharmaceuticals | 56 | |
| Eugene III | Biofrontera | 39 | |
| BComm BCom | Akanda Corp | 68 | |
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
| Sandra Beaver | Evolus Inc | 46 | |
| BCom BAcc | Akanda Corp | 44 | |
| Erica CPA | Biofrontera | 39 | |
| Hermann Lubbert | Biofrontera | 68 | |
| Jeff Holm | Biofrontera | N/A | |
| OriMoni Mimon | INC Research Holdings | 36 | |
| Mark Baldyga | Biofrontera | N/A | |
| Marlo Manning | Collegium Pharmaceutical | N/A | |
Management Performance
| Return On Equity | -3.3 | |||
| Return On Asset | -0.66 |
Love Hemp Group Leadership Team
Elected by the shareholders, the Love Hemp's board of directors comprises two types of representatives: Love Hemp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Love. The board's role is to monitor Love Hemp's management team and ensure that shareholders' interests are well served. Love Hemp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Love Hemp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Martin, Chief Officer | ||
| Stephen White, Chief Officer | ||
| Ian Munzberger, Chief Officer | ||
| Anna Legge, Chief Officer | ||
| Antonio Calamita, CEO Founder | ||
| Steve Horan, Head Marketing | ||
| Adam Pritchard, Chief Officer | ||
| Anthony Dyer, Director CFO | ||
| Martin Healy, Chief Officer |
Love Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Love Hemp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.3 | |||
| Return On Asset | -0.66 | |||
| Profit Margin | (2.25) % | |||
| Operating Margin | (2.24) % | |||
| Current Valuation | 2.51 M | |||
| Shares Outstanding | 829.15 M | |||
| Shares Owned By Insiders | 24.14 % | |||
| Shares Owned By Institutions | 0.12 % | |||
| Price To Book | 0.09 X | |||
| Price To Sales | 0.99 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Love Pink Sheet
Love Hemp financial ratios help investors to determine whether Love Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Love with respect to the benefits of owning Love Hemp security.